)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Abpro Holdings
Abpro Holdings (ABP) investor relations material
Abpro Holdings Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Focused on next-generation antibody therapeutics in immuno-oncology, ophthalmology, and infectious disease, with lead candidates ABP-102 and ABP-201 in early-stage development.
Securities delisted from Nasdaq in February 2026, now trading on OTC Pink Limited Market, impacting liquidity and capital-raising ability.
Significant cost reductions implemented, including R&D personnel furloughs and terminations in late 2025.
Financial highlights
No revenue generated for the three or six months ended June 30, 2026 or 2025.
Net loss for Q2 2026 was $0.9M, a 68% improvement from $3.0M in Q2 2025; six-month net loss was $2.0M, a 71% improvement from $6.9M in 2025.
Operating expenses for Q2 2026 were $1.2M, down 48% year-over-year; six-month operating expenses were $2.1M, down 60%.
Cash as of June 30, 2026 was $4.2M.
Outlook and guidance
Management concluded there is substantial doubt about the ability to continue as a going concern within one year due to insufficient cash to cover liabilities.
Plans to seek additional funding through equity, debt, collaborations, and grants; may need to further reduce operations if funding is not secured.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Abpro Holdings
- Net loss improved to $1.0M, but delisting and legal risks threaten liquidity and operations.ABP
Q1 2026 - Net loss narrowed to $2.9M in 2025, but liquidity and going concern risks remain acute.ABPQ4 2025
- Vote seeks to extend the business combination deadline, with redemption rights preserved.ABPProxy Filing
- Preclinical biotech with major funding needs registers large share and warrant resale, faces high dilution risk.ABPRegistration Filing
- Preclinical biotech with urgent capital needs registers up to 20.7M shares for resale under $50M SEPA.ABPRegistration Filing
- Shareholders will vote on extending the business combination deadline or face company liquidation.ABPProxy Filing
- Key votes include director re-election, auditor ratification, and a 1-for-10 reverse stock split.ABPProxy Filing
- Biotech registers major share resale and warrant exercise, faces funding and clinical risks.ABPRegistration Filing
- Biotech seeks $50M equity via SEPA amid going concern, dilution, and Nasdaq risks.ABPRegistration Filing
Next Abpro Holdings earnings date
Q3 202613 Nov, 2026
Abpro Holdings
Next Abpro Holdings earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage